Showing results (501-510 of 657) with videos related to
Sort By:
Pageof 66
BMC Medicine|January 29, 2024
Impact of preconception and antenatal supplementation with myo-inositol, probiotics, and micronutrients on offspring BMI and weight gain over the first 2 yearsJaz Lyons-Reid, José G B Derraik, Timothy Kenealy, et al.Enfermedades Infecciosas Y Microbiologia Clinica|March 25, 2014
[Diagnosis and treatment of imported malaria in Spain: Recommendations from the Malaria Working Group of the Spanish Society of Tropical Medicine and International Health (SEMTSI)]Jose Muñoz, Gerardo Rojo-Marcos, Germán Ramírez-Olivencia, et al.Neoplasia (New York, N.Y.)|January 12, 2013
MicroRNA expression profiling of peripheral blood samples predicts resistance to first-line sunitinib in advanced renal cell carcinoma patientsAngelo Gámez-Pozo, Luis M Antón-Aparicio, Cristina Bayona, et al.Journal of Geriatric Oncology|June 26, 2020
First-line panitumumab plus capecitabine for the treatment of older patients with wild-type RAS metastatic colorectal cancer. The phase II, PANEL studyJosé Carlos Méndez Méndez, Mercedes Salgado Fernández, Juan de la Cámara Gómez, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 28, 2022
Late presentation of human T-lymphotropic virus type 1 infection in Spain reflects suboptimal testing strategiesCarmen de Mendoza, Leire Pérez, Mario Fernández-Ruiz, et al.Diabetes, Obesity & Metabolism|February 5, 2024
Higher early pregnancy plasma myo-inositol associates with increased postprandial glycaemia later in pregnancy: Secondary analyses of the NiPPeR randomized controlled trialShiao-Yng Chan, Han Zhang, Jui-Tsung Wong, et al.Breast Cancer Research : BCR|November 7, 2013
Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: a pooled analysisBella Pajares, Marina Pollán, Miguel Martín, et al.Clinical and Experimental Rheumatology|October 7, 2020
Autoimmune congenital heart block and primary Sjögren's syndrome: characterisation and outcomes of 49 casesPilar Brito-Zerón, Sandra G Pasoto, Angel Robles-Marhuenda, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2014
Primary results of ROSE/TRIO-12, a randomized placebo-controlled phase III trial evaluating the addition of ramucirumab to first-line docetaxel chemotherapy in metastatic breast cancerJohn R Mackey, Manuel Ramos-Vazquez, Oleg Lipatov, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2015
Phase III trial evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for advanced breast cancer: the letrozole/fulvestrant and avastin (LEA) studyMiguel Martín, Sibylle Loibl, Gunter von Minckwitz, et al.Pageof 66